The registration number F20200000284 for AVT trehalose (for injection) has been publicly announced and completed dual reporting between China and the United States. You can check the registration information of active pharmaceutical ingredients, pharmaceutical excipients, and drug packaging materials through the CDE entrance. The following is a screenshot of the query results.

AVT offers multiple levels of trehalose for you to choose from, including trehalose (for injection) (sterile) Hipo-S, trehalose (for injection) Hipo-I, and trehalose (medical grade) Hipo-M, meeting the development needs of various injections such as biological products, blood products, and liposomes.


The following is a comparison of different levels of trehalose

Trehalose (for injection) (sterile) - Hipo-S

·Production in sterile GMP environment, relatively lowNeidu Su(<0.1iu>· Meets the pharmacopoeia standards of various countries, ChP,USP,JP,EP
·Assist with domestic and foreign application
·CDE Registration Number: F20190000452
·DMF Number: 034401

Trehalose (for injection) - Hipo-I

·Chao has a high cost-effectiveness and low content (<2.5iu>), which meets the pharmacopoeia standards of various countries, ChP,USP,JP,EP
·Support domestic application
·CDE registration number: F20200000284


Aiweituo (Shanghai) Pharmaceutical Technology Co., Ltd. has been focusing on high-level injection fields such as liposomes, fat emulsions, micro nano targeted preparations, and biologics for more than ten years. We have developed a unique sales model of "university+research institute+enterprise". Aiweituo, never forgetting its original intention, focuses on providing support and services for the high-level injection field.